Related Experiment Video
Updated: Apr 11, 2026

07:41
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
9.7K
Integrative network-based approach identifies key genetic elements in breast invasive carcinoma
BMC Genomics
|June 5, 2015
Summary
This study identifies key genes, miRNAs, and mutations driving breast cancer using an integrative network approach. These findings offer potential new drug targets for breast cancer treatment.
Area of Science:
- Genomics
- Bioinformatics
- Cancer Research
Background:
- Breast cancer is a prevalent and deadly disease with high mortality.
- Accurate classification and identification of genetic drivers are crucial for improved treatment and prognosis.
- Existing genomic and epigenomic data necessitate novel integrative approaches to identify key drivers.
Purpose of the Study:
- To develop and present an integrative network-based approach for identifying breast cancer drivers.
- To associate regulatory network interactions with breast carcinoma development.
- To integrate diverse datasets including gene expression, DNA methylation, miRNA expression, and somatic mutations.
Main Methods:
- An integrative network-based approach was employed.
- Integration of gene expression, DNA methylation, miRNA expression, and somatic mutation datasets.
- Analysis of regulatory interactions (TF-gene, miRNA-mRNA) and somatic variant proximity.
Main Results:
- Strong associations were found between regulatory elements from different data sources.
- Identified 106 candidate driver genes, 68 miRNAs, and 9 mutations in breast cancer.
- Discovered regulatory interactions among key drivers; some genes are targeted by anti-cancer drugs, and miRNAs are implicated in multiple cancers.
Conclusions:
- The integrated analysis expands knowledge of genomic drivers (genes, miRNAs, mutations) in breast cancer.
- Identified key drivers show evidence of involvement in breast carcinoma development.
- These genomic drivers warrant further investigation as potential therapeutic targets, and the approach is applicable to other diseases.
